Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 20 clinical trials
Accurate Dosimetry and Biomarkers Improve Survival in HCC Patients Treated With Resin 90 Yttrium (90Y)-Microspheres (DOSEY90)

This trial involves patients with hepatocellular carcinoma (HCC) diagnosis treated with transarterial radioembolization (TARE) with resin microspheres loaded with 90Y. Patients will be divided

  • 0 views
  • 23 Mar, 2022
  • 1 location
Yttrium-90 Radioembolization for Cirrhosis-Associated Thrombocytopenia

Evaluate the safety and efficacy of Yttrium-90 (90Y) radioembolization for the management of thrombocytopenia.

electrolytes
venous pressure
cirrhosis
varices
hepatic venous pressure gradient
  • 9 views
  • 25 Feb, 2022
  • 1 location
CapTem Plus Radioembolization for NET Liver Metastases

active regimen in this disease. Both drugs are radiosensitizers, and in a safety and feasibility study were combined with yttrium-90 radioembolization with acceptable additive toxicities and better than

  • 0 views
  • 10 Oct, 2021
  • 1 location
Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer (iRE-C)

This clinical trial will be conducted as a single-center, open-label, Phase I/2 trial to evaluate the feasibility and safety of Yttrium-90 radioembolization (Y90-RE) in combination with a fixed

vascular endothelial growth factor
liver metastasis
serum pregnancy test
fluoropyrimidine
oophorectomy
  • 0 views
  • 08 Apr, 2022
  • 1 location
Radioembolization of Primary and Secondary Liver Malignancies and The Effect On The Immune System

The goal of this study is to understand the immunologic effects radioembolization has on the immune system. This will be done by evaluating the changes on biopsy, peripheral blood monocytes, and

cancer
carcinoma
radioembolization
hepatocellular carcinoma
cytokines
  • 0 views
  • 16 Feb, 2022
  • 1 location
Durvalumab and Tremelimumab After Radioembolization for the Treatment of Unresectable Locally Advanced Liver Cancer

This phase Ib trial investigates the side effects of durvalumab and tremelimumab after radioembolization (radiation particles against liver tumors) and to see how well they work in treating

  • 0 views
  • 20 Aug, 2021
  • 1 location
Contrast-Enhanced Ultrasound for the Prediction of Bile Duct Cancer Response to Radioembolization Treatment

This clinical trial tests whether contrast-enhanced ultrasound can predict the response of bile duct cancer to targeted radiotherapy (radioembolization treatment). Contrast-enhanced ultrasound

cancer
  • 0 views
  • 06 May, 2022
  • 1 location
Perflutren Protein-Type A Microspheres and Contrast-Enhanced Ultrasound in Improving Response to Radioembolization Therapy in Patients With Liver Cancer

This phase II trial studies how well perflutren protein-type A microspheres and contrast-enhanced ultrasound work in improving response to radioembolization therapy in patients with liver cancer

cancer
carcinoma
liver cancer
radioembolization
hepatocellular carcinoma
  • 14 views
  • 12 Nov, 2021
  • 1 location
Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow Surrounding HAE

to radioembolization and/or help demonstrate radiation toxicity to the surrounding liver.

measurable disease
tumor burden
serum bilirubin
carcinoma
radioembolization
  • 0 views
  • 17 Feb, 2022
  • 1 location
Y90 Radiation Segmentectomy vs SBRT for HCC

transarterial Y90 radioembolization (radiation segmentectomy) versus stereotactic body radiation therapy (SBRT) for solitary early stage ( 3cm) hepatocellular carcinoma (HCC).

serum bilirubin
  • 0 views
  • 08 Sep, 2021
  • 1 location